Disclaimer: This is a simplified summary of a public company filing. See full disclaimer here.

ADM TRONICS UNLIMITED, INC.

CIK: 8494012 Annual ReportsLatest: 2025-07-14

10-K / July 14, 2025

Revenue:$3,197,110
Income:-$123,056

10-K / July 15, 2024

Revenue:$2,965,406
Income:-$877,222

10-K / July 14, 2025

Company Summary

Business Overview

  • Type: Technology-based developer and manufacturer
  • Founded: November 24, 1969
  • Legal Structure: Corporation organized under Delaware laws
  • Operations Conducted Through: ADM Tronics Unlimited, Inc. ("ADM") and its subsidiary Sonotron Medical Systems, Inc. ("SMI")

Core Activities

  • Electronics for Medical Devices and Other Applications:

    • Develops and manufactures electronic technologies for non-invasive, electrotherapeutic, and diagnostic medical devices
    • Serves veterinary and other applications
    • Manufacturing occurs at FDA-Registered Medical Device Manufacturing facility in Northvale, NJ
    • Produces both proprietary products and contract manufacturing for third-party companies
    • As of March 31, 2025, backlog for electronic product orders was approximately $956,000
  • Environmentally Safe Chemical Products for Industrial Uses:

    • Develops, manufactures, and sells water-based chemicals such as primers, adhesives, coatings, resins, chemical additives, and anti-static conductive paints
    • Products used in industries like printing, food packaging, and manufacturing
    • Emphasizes environmentally friendly, water-based systems as alternatives to solvent-based systems, claiming no known polluting effects or health hazards
    • No patents protect these chemical formulations; some product names are trademarked
    • Backlog for chemical products as of March 31, 2025, was not material
  • Medical and Cosmetic Products:

    • Proprietary water-based, adhesive, and topical formulations for medical applications such as maxillofacial prosthetics
    • Used for professional makeup and special effects in film, TV, and theater
  • Research, Development, Regulatory, and Engineering Services:

    • Provides R&D, regulatory compliance, and engineering support for third parties in designing, developing, and manufacturing medical devices, electronics, and related technologies
    • Services provided both on a fee-for-services and project basis

Customer Base

  • During fiscal year ending March 31, 2025:
    • 2 major customers accounted for 48% and 44% of net revenue
    • Out of accounts receivable: 55% and 54% were from these customers

Market and Distribution

  • Products are sold directly from Northvale, NJ, on FOB shipping basis
  • Uses distributors who stock and ship products on their behalf
  • Revenue depends heavily on a limited number of customers, making the company vulnerable if major customers are lost

Employees

  • Number of Employees: Not specified in the provided text

Financials

  • Revenue and Income:
    • Exact revenue and income figures are not provided in this excerpt
    • Focuses on backlog amounts, customer concentration, and operational factors rather than specific financial results

Other Key Details

  • Facilities: Located at 224 Pegasus Avenue, Northvale, NJ
    • Leased approximately 16,000 sq. ft. space, expiring June 2028
  • Regulatory & Compliance:
    • Manufacturing facility FDA-registered since 1988
    • Complies with FDA quality standards and regulations
  • Patents & Trademarks:
    • No patents on chemical products; some trademarks for product names
  • Research & Development Expenses:
    • Fiscal years ending March 31, 2025 and 2024: $517,275 and $576,903 respectively

Summary

The company develops and manufactures electronics for medical and veterinary applications, produces environmentally friendly chemical products for industrial uses, and provides R&D and regulatory services for medical devices and electronics. It relies on a small number of major customers, maintains a single manufacturing facility, and faces typical industry regulatory and supply chain challenges.